Literature DB >> 27460602

Two-year changes in circulating adiponectin, ectopic fat distribution and body composition in response to weight-loss diets: the POUNDS Lost Trial.

W Ma1, T Huang2, M Wang1, Y Zheng3, T Wang2, Y Heianza2, D Sun2, S R Smith4, G A Bray5, F M Sacks3, L Qi1,2,3,6.   

Abstract

BACKGROUND/
OBJECTIVES: Adiponectin has a pivotal role in linking fat distribution with cardiometabolic disorders. We investigated the associations of long-term changes in circulating adiponectin with body composition and fat distribution at different abdominal depots in response to weight-loss dietary interventions, as well as the modification effect of sex. SUBJECTS/
METHODS: In the 2-year Preventing Overweight Using Novel Dietary Strategies (POUNDS Lost) Trial, 811 overweight or obese adults were randomly assigned to one of four diets varying in macronutrient intakes. Circulating concentrations of adiponectin were repeatedly measured at baseline, 6 months and 2 years. Body composition and fat distribution were repeatedly measured by dual-energy X-ray absorptiometry scan (n=424) and computed tomography (n=195).
RESULTS: Over the 2-year intervention, after adjustment for age, sex, ethnicity, follow-up time, diet group, baseline body mass index and baseline level of respective outcome trait, increase of adiponectin was significantly associated with reduction of total fat mass (FM), total fat-free mass (FFM), whole body total percentage of fat mass (FM%), percentage of trunk fat (TF%), total adipose tissue (TAT), and adipose tissue mass at different depots including visceral (VAT), deep subcutaneous (DSAT) and superficial subcutaneous (SSAT; P<0.03 for each). The relations with FM, FM%, TF%, VAT and DSAT were significantly modified by sex (P for interaction=0.02, 0.005 and <0.001, 0.002, 0.03, respectively) with greater reductions associated with increase of adiponectin in men than in women.
CONCLUSIONS: Long-term changes in circulating adiponectin were differentially associated with improvement of body composition and abdominal fat distribution in men and women.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27460602     DOI: 10.1038/ijo.2016.128

Source DB:  PubMed          Journal:  Int J Obes (Lond)        ISSN: 0307-0565            Impact factor:   5.095


  42 in total

1.  The relationships of plasma adiponectin with a favorable lipid profile, decreased inflammation, and less ectopic fat accumulation depend on adiposity.

Authors:  Konstantinos Kantartzis; Killian Rittig; Bernd Balletshofer; Jürgen Machann; Fritz Schick; Katarina Porubska; Andreas Fritsche; Hans-Ulrich Häring; Norbert Stefan
Journal:  Clin Chem       Date:  2006-08-17       Impact factor: 8.327

2.  Adipose tissue mass and location affect circulating adiponectin levels.

Authors:  A T Turer; A Khera; C R Ayers; C B Turer; S M Grundy; G L Vega; P E Scherer
Journal:  Diabetologia       Date:  2011-07-22       Impact factor: 10.122

3.  Subcutaneous and total fat at L4-L5 and subcutaneous, visceral and total fat at L3-L4 are important contributors of fasting and postprandial adiponectin levels.

Authors:  Simoni A Katergari; Ploumis Passadakis; Athanasios Milousis; Theoktisti Passadaki; Byron Asimakopoulos; Michael Mantatzis; Panagiotis Prassopoulos; Grigorios Tripsianis; Nikolaos Nikolettos; Dimitrios N Papachristou
Journal:  Endocr Res       Date:  2015-03-16       Impact factor: 1.720

4.  Total and high-molecular-weight adiponectin and resistin in relation to the risk for type 2 diabetes in women.

Authors:  Christin Heidemann; Qi Sun; Rob M van Dam; James B Meigs; Cuilin Zhang; Shelley S Tworoger; Christos S Mantzoros; Frank B Hu
Journal:  Ann Intern Med       Date:  2008-09-02       Impact factor: 25.391

5.  Adiponectin gene expression in subcutaneous adipose tissue of obese women in response to short-term very low calorie diet and refeeding.

Authors:  Yong-Ming Liu; Jean-Marc Lacorte; Nathalie Viguerie; Christine Poitou; Véronique Pelloux; Bernard Guy-Grand; Christiane Coussieu; Dominique Langin; Arnaud Basdevant; Karine Clément
Journal:  J Clin Endocrinol Metab       Date:  2003-12       Impact factor: 5.958

6.  Lower expression of adiponectin mRNA in visceral adipose tissue in lean and obese subjects.

Authors:  Aina S Lihn; Jens M Bruun; Gengsheng He; Steen B Pedersen; Peter F Jensen; Bjørn Richelsen
Journal:  Mol Cell Endocrinol       Date:  2004-04-30       Impact factor: 4.102

Review 7.  Physiological, pharmacological, and nutritional regulation of circulating adiponectin concentrations in humans.

Authors:  Michael M Swarbrick; Peter J Havel
Journal:  Metab Syndr Relat Disord       Date:  2008-06       Impact factor: 1.894

8.  Sex differences in the relation of visceral adipose tissue accumulation to total body fatness.

Authors:  S Lemieux; D Prud'homme; C Bouchard; A Tremblay; J P Després
Journal:  Am J Clin Nutr       Date:  1993-10       Impact factor: 7.045

9.  Adipose tissue depot and cell size dependency of adiponectin synthesis and secretion in human obesity.

Authors:  Lauren K Meyer; Theodore P Ciaraldi; Robert R Henry; Alan C Wittgrove; Susan A Phillips
Journal:  Adipocyte       Date:  2013-05-07       Impact factor: 4.534

10.  Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase.

Authors:  T Yamauchi; J Kamon; Y Minokoshi; Y Ito; H Waki; S Uchida; S Yamashita; M Noda; S Kita; K Ueki; K Eto; Y Akanuma; P Froguel; F Foufelle; P Ferre; D Carling; S Kimura; R Nagai; B B Kahn; T Kadowaki
Journal:  Nat Med       Date:  2002-10-07       Impact factor: 53.440

View more
  7 in total

1.  Dynamic relationships between body fat and circulating adipokine levels from adolescence to young adulthood: The Santiago Longitudinal Study.

Authors:  Daeeun Kim; Annie Green Howard; Estela Blanco; Raquel Burrows; Paulina Correa-Burrows; Aylin Memili; Cecilia Albala; José L Santos; Bárbara Angel; Betsy Lozoff; Anne E Justice; Penny Gordon-Larsen; Sheila Gahagan; Kari E North
Journal:  Nutr Metab Cardiovasc Dis       Date:  2022-01-07       Impact factor: 4.666

2.  History of Asthma From Childhood and Arterial Stiffness in Asymptomatic Young Adults: The Bogalusa Heart Study.

Authors:  Dianjianyi Sun; Xiang Li; Yoriko Heianza; Hoirun Nisa; Xiaoyun Shang; Felicia Rabito; Tanika Kelly; Emily Harville; Shengxu Li; Jiang He; Lydia Bazzano; Wei Chen; Lu Qi
Journal:  Hypertension       Date:  2018-05       Impact factor: 10.190

3.  Genetic, epigenetic and transcriptional variations at NFATC2IP locus with weight loss in response to diet interventions: The POUNDS Lost Trial.

Authors:  Dianjianyi Sun; Yoriko Heianza; Xiang Li; Xiaoyun Shang; Steven R Smith; George A Bray; Frank M Sacks; Lu Qi
Journal:  Diabetes Obes Metab       Date:  2018-05-24       Impact factor: 6.577

Review 4.  Obesity genetics and cardiometabolic health: Potential for risk prediction.

Authors:  Dharambir K Sanghera; Cynthia Bejar; Sonali Sharma; Rajeev Gupta; Piers R Blackett
Journal:  Diabetes Obes Metab       Date:  2019-03-20       Impact factor: 6.577

Review 5.  The Influence of Nutrition on Adiponectin-A Narrative Review.

Authors:  Justyna Janiszewska; Joanna Ostrowska; Dorota Szostak-Węgierek
Journal:  Nutrients       Date:  2021-04-21       Impact factor: 5.717

Review 6.  Gene-Diet Interaction and Precision Nutrition in Obesity.

Authors:  Yoriko Heianza; Lu Qi
Journal:  Int J Mol Sci       Date:  2017-04-07       Impact factor: 5.923

7.  Adiponectin deficiency contributes to the development and progression of benign prostatic hyperplasia in obesity.

Authors:  Shi Fu; Huan Xu; Meng Gu; Chong Liu; Qiong Wang; Xiang Wan; Yanbo Chen; Qi Chen; Yubing Peng; Zhikang Cai; Juan Zhou; Zhong Wang
Journal:  Sci Rep       Date:  2017-03-03       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.